Although there are no approved sarcopenia drugs at present, ongoing research is exploring possible pharmacological solutions. Investigational treatments include Selective Androgen Receptor Modulators (SARMs) and myostatin inhibitors, which aim to enhance muscle mass and function. Beyond non-pharmacological approaches, some individuals reported using a range of drug therapies and medical procedures to address sarcopenia or related conditions. These included ibutamoren, creatine, fluconazole, interferon, teriparatide, etanercept, as well as surgeries for arthritis, cancer, and cardiovascular disease. At the moment, the clinical sarcopenia pipeline shows a notable absenc...
